SANARA MEDTECH INC. Asset Acquisition Consideration Transferred Transaction Cost
SANARA MEDTECH INC. (SMTI) had Asset Acquisition Consideration Transferred Transaction Cost of $162.74 thousand as of 2023-08-01, per its 10-Q filed 2024-08-12.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Asset Acquisition, Consideration Transferred
us-gaap:AssetAcquisitionConsiderationTransferredTransactionCost · last filed 2024-08-12
- 2023-08-01: Asset Acquisition Consideration Transferred Transaction Cost $162.74K.
- 2023-04-01: Asset Acquisition Consideration Transferred Transaction Cost $162.74K.
| Period end | Asset Acquisition Consideration Transferred Transaction Cost |
|---|---|
| 2023-08-01 | $162.74K 10-Q · filed 2024-08-12 |
| 2023-04-01 | $162.74K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B |